๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Altered interrelationship of dopamine, prolactin, thyrotropin and thyroid hormone in schizophrenic patients

โœ Scribed by Marie Luise Rao; Gisela Gross; Gerd Huber


Publisher
Springer-Verlag
Year
1984
Tongue
English
Weight
495 KB
Volume
234
Category
Article
ISSN
1433-8491

No coin nor oath required. For personal study only.

โœฆ Synopsis


Increased dopaminergic activity has been postulated to be one of the main causes of schizophrenia. To evaluate this hypothesis further, the interrelation between dopamine, prolactin, thyrotropin (TSH) and L-thyroxine was studied by determining their concentrations in the serum of ten acutely ill schizophrenic patients exhibiting distinct stages of process activity and ten healthy subjects. The level of dopamine was elevated in the sera of schizophrenic patients, whereas the levels of prolactin, TSH and L-thyroxine were decreased. On the basis of these results we hypothesize that 1. increased dopaminergic activity affects pituitary secretory function, and 2. decreased beta-adrenergic activity may be a consequence of decreased thyroid hormone concentration in plasma.


๐Ÿ“œ SIMILAR VOLUMES


Thyroid hormones in benign breast diseas
โœ Friedolf Peters; C. Renate Pickardt; Meinert Breckwoldt ๐Ÿ“‚ Article ๐Ÿ“… 1985 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 413 KB ๐Ÿ‘ 2 views

To investigate the exaggerated prolactin (PRL) responsiveness to thyrotropin-releasing hormone (TRH) in patients with benign breast disease (BBD), 18 patients and 13 healthy controls underwent an 8-week-long thyroid hormone treatment. The clinical effect of thyroid hormones on cyclical mastodynia an

Stage-dependent depression of melatonin
โœ Christian Bartsch; Hella Bartsch; Ute Fuchs; Theodor H. Lippert; Otto Bellmann; ๐Ÿ“‚ Article ๐Ÿ“… 1989 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 816 KB

Serum melatonin was determined over 24 hours in 35 patients with breast cancer with either a fresh primary tumor (n = 23) or a secondary tumor (n = 12) and in 28 patients with untreated benign breast disease (controls) having a fibroadenoma (n = lo), fibrocystic mastopathy (n = 14), or other breast